Previous 10 | Next 10 |
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Anavex To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - March 20, 2024) - Faruqi & Faruqi, LLP, a leading national se...
NEW YORK, NY / ACCESSWIRE / March 20, 2024 / Bernstein Liebhard LLP: Do you, or did you, own shares of Anavex Life Sciences Corporation (NASDAQ:AVXL)? Did you purchase your shares between February 1, 2022 and January 1, 2024, inclusive? Did you lose money in your investment in Anavex Li...
First patient screened ahead of schedule Trial to investigate positive, negative, and cognitive domains of schizophrenia ANAVEX ® 3-71’s differentiated dual novel mechanism of action offers the potential to synergistically activate both SIGMAR1 and M1 muscarinic ...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Anavex To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - March 17, 2024) - Faruqi & Faruqi, LLP, a leading national se...
2024-03-15 16:48:33 ET Gainers: 89bio ( ETNB ) +5% . Black Diamond Therapeutics ( BDTX ) +5% . Anavex Life Sciences ( AVXL ) +3% . iHeartMedia ( IHRT ) +2% . SMART Global Holdings ( SGH ) +2% . Losers: CERo Th...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Anavex To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - March 14, 2024) - Faruqi & Faruqi, LLP, a leading natio...
NEW YORK, March 14, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired securities...
NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders ...
2024-02-07 12:46:02 ET Anavex Life Sciences Corp. (AVXL) Q1 2024 Earnings Conference Call February 7, 2024 8:30 AM ET Company Participants Christopher Missling – President and Chief Executive Officer Sandra Boenisch – Principal Financial Officer C...
2024-02-07 07:35:23 ET More on Anavex Life Sciences Anavex: The Pediatric Rett Trial Failure Is Disastrous How Soon Might Anavex's Alzheimer's Drug Be Approved? The Good/Bad News Anavex Life Sciences: Rett Safety Dance With Broader CNS Implications (Rating Downgrade)...
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigatin...
SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain inv...
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceuti...